Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06969521 · ClinicalTrials.gov registry record · NA

Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics

A NA study of Speech Sound Disorder, sponsored by Montclair State University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06969521: Recruiting NA study of Speech Sound Disorder, sponsored by Montclair State University.

NCT06969521 is a NA study of Speech Sound Disorder that is actively recruiting participants, run by Montclair State University. The registered enrollment target is 60 participants, below the 85-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06969521, a NA study of Speech Sound Disorder, is actively recruiting participants, sponsored by Montclair State University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine whether perceptual training enhances speech perception and production outcomes in children with Residual Speech Sound Disorders (RSSD). The main questions it aims to answer are: Does pre-treatment speech production accuracy predict treatment response? Does perceptual acuity influence the effectiveness of perception-first versus production-first interventions? Researchers will compare TAU+Perception-first and TAU-first treatment conditions to see if the order of intervention affects speech improvement outcomes, particularly based on participants' initial perception and production accuracy. Participants will: Complete pre-treatment evaluations to assess /r/ production and speech perception. Be grouped into high or low production and perception accuracy categories based on established thresholds. Be randomly assigned (using a blocked randomization procedure) to one of two treatment arms via telepractice. Participate in the assigned treatment condition designed to target speech sound accuracy. Randomization is stratified to ensure treatment groups are balanced based on pre-treatment severity in both the perception and production domains.

Primary Outcome

To assess generalization of treatment gains to untreated words, participants will be assessed with standard probes containing 45 syllables, 50 words and 5 sentences with rhotic targets in various phonetic contexts. Stimuli in each probe will be presented individually in randomized order with blocking by stimulus type (word, syllable, sentence). No auditory models will be provided; for children with reading difficulty, semantic cues will be provided to elicit the intended word. Individual words

Conditions Studied

Interventions

  • BEHAVIORAL Visual acoustic biofeedback: ORDER
  • BEHAVIORAL Perception Training: ORDER

Study Locations (1)

New Jersey

  • Montclair State University - Montclair

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-05-10
Est. Completion 2027-07-01
Phase NA
Montclair State University

8 total trials

What NCT06969521 shows while recruiting

NCT06969521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 85-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (29% lower).

The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which Visual acoustic biofeedback: ORDER is the first listed.

NCT06969521 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06969521 about?

NCT06969521 is a clinical study titled "Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics". The goal of this clinical trial is to determine whether perceptual training enhances speech perception and production outcomes in children with Residual Speech Sound Disorders (RSSD). The main questions it aims to answer are: Does pre-treatment speech production accuracy predict treatment response?...

What is the current status of trial NCT06969521?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-10. Estimated completion is 2027-07-01.

What conditions does trial NCT06969521 study?

This clinical trial studies the following conditions: Speech Sound Disorder.

What interventions are being tested in trial NCT06969521?

The interventions under investigation include: Visual acoustic biofeedback: ORDER (BEHAVIORAL), Perception Training: ORDER (BEHAVIORAL).

Who is sponsoring clinical trial NCT06969521?

This trial is sponsored by Montclair State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06969521 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech Sound Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06969521's enrollment target sits among peer trials

60 8th of 15 higher than 7 of 15 other Speech Sound Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06969521, the US trial registry maintained by the National Library of Medicine. NCT06969521 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.